Lauren Schaff

Associate Director, Neuro-Oncology Fellowship Program · New York Presbyterian Hospital

Credentials: · · · ·

History

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
Principal investigator · Active not recruiting · Early phase 1
Memorial Sloan Kettering Cancer Center
2018–2027
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2026–2040
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Site PI · Recruiting · Phase 1, Phase 2
Tango Therapeutics, Inc.
2025–2027